Markets:

Overview

News

Currencies

International

Treasuries

BeyondSpring, Inc. - Ordinary Shares (NQ:BYSI)

1.900 -0.080 (-4.04%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BeyondSpring, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 26, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 68.43% to $17.18 during Friday's pre-market session. The market value of their outstanding shares is at $119.6...

Via Benzinga

25 Stocks Moving in Friday's Pre-Market Session ↗

November 26, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 25, 2021

Gainers XTL Biopharmaceuticals (NASDAQ:XTLB

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 24, 2021

Gainers iSpecimen (NASDAQ:ISPC) shares in...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 22, 2021

Gainers Qualigen Therapeutics (NASDAQ:QLGN

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates ↗

November 02, 2021

The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...

Via Benzinga

3 Biotech Stocks With Huge Catalysts Incoming ↗

October 22, 2021

These drugmakers have big events that should occur before the end of 2021.

Via The Motley Fool

48 Biggest Movers From Yesterday ↗

September 21, 2021

Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge ↗

September 20, 2021

Toward the end of trading Monday, the Dow traded down 2.57% to 33,696.98 while the NASDAQ fell 3.14% to 14,572.25. The S&P also fell, dropping 2.58% to 4,318.67. The U.S. has...

Via Benzinga

Topics Stocks

Why Are BeyondSpring's Shares Plunging Today? ↗

September 20, 2021

BeyondSpring Pharmaceuticals Inc (NASDAQ: BYSI) shared the final intention-to-treat (ITT) dataset from its DUBLIN-3 Phase 3 trial of plinabulin. The trial...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 20, 2021

Gainers Atea Pharmaceuticals (NASDAQ:AVIR) shares increased by 13.83% to $29.86 during Monday's regular session. Trading volume for this security as of 12:30 EST is 3....

Via Benzinga

Mid-Day Market Update: Crude Oil Down 2%; Synlogic Shares Spike Higher ↗

September 20, 2021

Midway through trading Monday, the Dow traded down 1.51% to 34,063.71 while the NASDAQ fell 2.13% to 14,723.20. The S&P also fell, dropping 1.64% to 4,360.41. The U.S. has the...

Via Benzinga

Topics Stocks

35 Stocks Moving In Monday's Mid-Day Session ↗

September 20, 2021

Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Brooks Automation Divests Semiconductor Business For $3B ↗

September 20, 2021

Following the market opening Monday, the Dow traded down 1.42% to 34,093.46 while the NASDAQ fell 1.86% to 14,763.93. The S&P also fell, dropping 1.54% to 4,364.65. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 20, 2021

Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million....

Via Benzinga

BeyondSpring Presents New Plinabulin Data At ESMO Congress ↗

September 16, 2021

BeyondSpring Pharmaceuticals (NASDAQ: BYSI) announced new plinabulin data from its chemotherapy-induced neutropenia (CIN) prevention program at the European...

Via Benzinga

BeyondSpring: Q2 Earnings Insights ↗

September 14, 2021

BeyondSpring(NASDAQ:BYSI) stock fell by 4.13% on Monday after the company reported their Q2 earnings results on Friday, September 10, 2021 at 07:00 AM. Here's what...

Via Benzinga

BeyondSpring inc (BYSI) Q2 2021 Earnings Call Transcript ↗

September 10, 2021

BYSI earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Earnings Scheduled For September 10, 2021 ↗

September 10, 2021

Companies Reporting Before The Bell • So-Young Intl (NASDAQ:SY) is projected to report quarterly earnings at $0.09 per share on revenue of $67.87 million. • Root...

Via Benzinga

Baird Initiates BeyondSpring With Outperform On Plinabulin Potential ↗

September 09, 2021

BeyondSpring Inc’s (NASDAQ:BYSI) lead candidate plin...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 08, 2021

Gainers Cardiff Oncology (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 01, 2021

Gainers Neuronetics (NASDAQ:STIM) stock rose 16.51% to $7.83 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 675.7K shares...

Via Benzinga

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

BYSI Stock: Why Did BeyondSpring Gain 15% on Tuesday? ↗

August 31, 2021

Today, some very positive news surrounding BeyondSpring's lead drug candidate has sent shares of BYSI stock soaring.

Via InvestorPlace

Week In Review: Suzhou Abogen Raises $700 Million For mRNA COVID-19 Vaccine ↗

August 28, 2021

Suzhou Abogen Biosciences raised over $700 million in a record-breaking Series C round to support a Phase III trial of its mRNA COVID-19 vaccine. The company has completed a Phase II trial of the...

Via Talk Markets

Why BeyondSpring Stock Is Soaring This Week ↗

August 27, 2021

A lucrative partnership deal with a pharmaceutical giant in China bodes well for BeyondSpring's potential new blockbuster cancer drug.

Via The Motley Fool

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

63 Biggest Movers From Yesterday ↗

August 27, 2021

Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

BeyondSpring, Inc. - Ordinary Shares (NQ:BYSI)

All News about BeyondSpring, Inc. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today